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Introduction
• In the early 1900’s, Dr. Alois Alzheimer discovered the
disease which would later bear his name.
• He observed an institutionalized patient with severe memory
impairment coupled with odd behavioral symptoms.
• After the patient’s death, Dr. Alzheimer examined the brain.
He was able to identify amyloid plaques and neurofibrillary
tangles within the structure.
• These findings helped to link the pathology with the clinical
symptoms associated with the disease (Grabher, 2018)..
Alzheimer’s is a degenerative disease of the brain which affects
tens of millions of people around the world. It is estimated to
include over 5 million patients in the United States. Over
200,000 patients with Alzheimer’s disease (AD) live in Ohio
(2019 Alzheimers disease facts and figures, 2019). The
numbers can be staggering. However, the selection of this topic
of study was limited to a single patient. He was this writer’s
father. The impact of observing the disease process steal the
function, memory and identity of a loved one cannot be
overstated.

There is no one singularly known cause of AD. There are multiple theories which attempt to explain the pathogenesis. However, more
research is required (Atri, 2019). Despite this AD is characterized by two distinctive features; the affected brain contains amyloid
plaques and neurofibrillary tangles (NFT’s). These abnormal protein fragments are found surrounding and incorporated within the
neurons. Amyloid plaques consist of a dense deposit of beta amyloid enveloping the exterior of the neuron. Plaque interfere with the
communication ability of the neuron at the synapse. As the plaque develop, the irritation of its presence creates tau proteins. Tau
proteins collect within the neuron. They present in a fibrous tangle preventing the transport of nutrients to the neuron. The presence
of these proteins causes disruption of neuronal function followed by neuronal death (Cummings, 2019).

Care considerations of the AD patient should focus on maintaining the highest level of independence

Amyloid plaques and tangles can be found in patients without impaired memory, dementia, or cognitive dysfunction. However, this
may indicate an increased risk of developing AD. A definitive diagnosis of AD requires both the cognitive changes associated with
dementia along with the plaques and NFT’s (Atri, 2019).

place promptly can slow the decline and avert further disability. Caregivers and family members should

Inflammation and atrophy are also present in the AD brain. The additional insult of the amyloid plaques and tangles is the activation of
an immune response in the brain. Microglia work to remove the amyloid and tau proteins, dead cells and other debris. However, the
when the microglia are unable to keep up with the cascade, an inflammatory reaction occurs (Cummings, 2019). Atrophy occurs due
to neuronal death. The brain structures shrink with cellular loss.

• Elevated blood pressure during a few office visits but no
prescribed medication.
• No children and previous hysterectomy.
• Well-groomed, alert and friendly.
• General and elemental neurological exams were normal.
•
•
•
•
•

Anomic aphasia.
Refers to items as "things" and "stuff".
Able to provide her name.
Unable to provide her age, date of birth, or the current year.
On formal testing, she scored well below average in all
cognitive domains.
• Perservates both verbal and motor responses.
The conclusion of the evaluation was that she met research
criteria for probable Alzheimer's disease. The patient would
require around the clock supervision and would benefit from
social stimulation provided in assisted living environment
(Johnson & Becker, n.d.).

safely possible. Implementation of strategies to preserve cognitive function, provide socialization and
retain functional abilities must be prioritized in any setting the AD patient is present. Early diagnosis
and treatment can slow progression. Patients and families should be assisted in the identification of
risk factors associated with AD. Lifestyle modifications can be encouraged. Interventions put into
be included whenever possible (Grabher, 2018).
• maintain quality of life
•

maximize function in daily activities

• enhance cognitive mood and behavior
•

foster a safe environment promote social engagement
(Aigbogun, Stellhorn, Krasa, & Kostic, 2017).

Conclusion

Case Study
A 73-year-old woman presented for neurological evaluation with
a 3-year history of memory impairment. Patient was a high
school graduate and worked as a secretary until retiring at age
65. She had lived alone maintained her own home and finances
since the death of her husband. Her brother noticed gradually
worsening memory and difficulty finding words, but the patient
became angered at the suggestion that she may have a
progressive impairment.

Nursing Considerations

Pathophysiological Processes

Picture 1. Healthy Neuron
([Nerve-cell], 2019).

Picture 2. AD Neuron
([Nerve-cell-alzheimer], 2019).

Signs and Symptoms
Some of the earliest signs and symptoms of AD appear years before a diagnosis. Patients may experience changes in mood, sleep
disruptions, and increased anxiety/depression. They are forgetful, and unable to create new memories. Symptoms can be
overlooked as they can be associated with other etiologies or confused with age related changes (Atri, 2019).
• Memory loss that disrupts daily life
• Challenges in planning or solving problems
• Difficulty in completing tasks at home, work or leisure
• Confusion with time or place
• New problems with words in speaking or writing
• Misplacing things and losing the ability to retrace steps
• Decreased or poor judgement
• Withdrawal from work or social activities
• Trouble understanding visual images or spatial relationships
• Changes in mood and personality

(Alzheimer's Association, 2019).

AD continues to overwhelm the world’s population. It impacts citizens of every country. 44 million people
worldwide are currently affected. As populations are living longer, it is expected the number of AD patients will
double by 2050 (Grabher, 2018). The medical, emotional, and financial burdens this will create are confounding.
It is imperative research continue to discover a cure for this disease
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